Compare VEEV & MKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VEEV | MKL |
|---|---|---|
| Founded | 2007 | 1930 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Property-Casualty Insurers |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.4B | 23.2B |
| IPO Year | 2013 | 1999 |
| Metric | VEEV | MKL |
|---|---|---|
| Price | $174.62 | $1,817.61 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 25 | 1 |
| Target Price | $280.42 | ★ $2,100.00 |
| AVG Volume (30 Days) | ★ 2.5M | 71.0K |
| Earning Date | 05-27-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.93 | N/A |
| EPS | ★ 5.44 | N/A |
| Revenue | $1,104,081,000.00 | ★ $15,513,233,000.00 |
| Revenue This Year | $14.42 | N/A |
| Revenue Next Year | $12.17 | $2.26 |
| P/E Ratio | $30.19 | ★ N/A |
| Revenue Growth | ★ 28.05 | N/A |
| 52 Week Low | $148.05 | $1,719.41 |
| 52 Week High | $310.50 | $2,207.59 |
| Indicator | VEEV | MKL |
|---|---|---|
| Relative Strength Index (RSI) | 61.57 | 43.50 |
| Support Level | $169.92 | $1,816.12 |
| Resistance Level | $184.71 | $1,876.58 |
| Average True Range (ATR) | 6.68 | 34.90 |
| MACD | 1.29 | 4.80 |
| Stochastic Oscillator | 89.20 | 34.77 |
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.